Skip to search formSkip to main contentSkip to account menu

LY2584702

Known as: p70S6K Inhibitor LY2584702 
An orally available inhibitor of p70S6K signaling, with potential antineoplastic activity. p70S6K inhibitor LY2584702 inhibits ribosomal protein S6… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Aims Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown dramatic clinical benefits in advanced… 
Highly Cited
2009
Highly Cited
2009
Human papilloma virus (HPV) infection of the uterine cervix is linked to the pathogenesis of cervical cancer. Preclinical in… 
2007
2007
Stimulation of cardiac beta-adrenergic receptors (beta-AR) activates both the G(s)- and G(i)-coupled signaling cascades… 
2007
2007
PPARγ ligands inhibit the proliferation of non-small cell lung carcinoma (NSCLC) cells in vitro. The mechanisms responsible for… 
2006
2006
Arsenic trioxide (As2O3) exhibits important antitumor activities in vitro and in vivo, but the precise mechanisms by which it… 
Highly Cited
2004
Highly Cited
2004
Difficulties in achieving long-term survival of lung cancer patients treated with conventional therapies suggest that novel… 
2002
2002
Anaplastic large cell lymphoma (ALCL) exhibiting the t(2;5) translocation is characterized by the resulting expression of the… 
Review
1996
Review
1996
Translational control has a key role in regulating cell growth. The mRNA binding translation factors (eIF4s) selectively modulate… 
Highly Cited
1995
Highly Cited
1995
Lactogens [prolactin (Prl) and growth hormone] stimulate phosphorylation of the 40S ribosomal protein, S6, in Nb2 cells by…